Internal Medicine · Greeley, CO
NPI
1730166687
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1900 16th St
Greeley, CO, 80631
Phone (970) 350-2438
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
2,769 services
Medicare patients, 2024
820
Average age 76
Drug cost, 2024
$2.4M
25,805 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark F Berntsen was code 99214 (office e&m - established), 828 times for 528 patients. In total Mark F Berntsen billed 2,769 services in 42 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 828 | 528 | $36.32 | $30K |
| 99213 Office E&M - Established | Office | 685 | 503 | $30.36 | $21K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 548 | 548 | $44.35 | $24K |
| G0008 Administration of influenza virus vaccine | Office | 114 | 113 | $32.58 | $3,714 |
| 90662 Vaccine Product | Office | 108 | 107 | $81.27 | $8,777 |
| 83036 Blood Count | Office | 68 | 58 | $9.38 | $638 |
| 93793 Care Management/Coordination | Office | 58 | 16 | $8.55 | $496 |
| 91320 Vaccine Product | Office | 56 | 50 | $143.03 | $8,010 |
| 90480 Vaccine Administration | Office | 56 | 50 | $43.45 | $2,433 |
| 99215 Office E&M - Established | Office | 49 | 16 | $40.29 | $1,974 |
| 93005 Electrocardiogram | Office | 31 | 31 | $4.68 | $145 |
| 90677 Vaccine Product | Office | 20 | 20 | $288.86 | $5,777 |
| G0009 Administration of pneumococcal vaccine | Office | 20 | 20 | $32.58 | $652 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 16 | 16 | $56.93 | $911 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 11 | 11 | $140.26 | $1,543 |
By year: 2022 $120K for 2,718 services; 2023 $115K for 2,747 services; 2024 $114K for 2,769 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 68 | 58 | $9.38 | $638 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark F Berntsen prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,362 prescriptions and refills. In total Mark F Berntsen wrote 25,805 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,362 | 3,733 | 344 | $13K |
| Amlodipine Besylate Generic | 1,252 | 3,440 | 332 | $6,726 |
| Atorvastatin Calcium Generic | 1,221 | 3,566 | 346 | $10K |
| Lisinopril Generic | 1,107 | 3,155 | 294 | $7,578 |
| Losartan Potassium Generic | 1,089 | 3,072 | 295 | $9,792 |
| Omeprazole Generic | 744 | 2,162 | 209 | $13K |
| Tamsulosin Hcl Generic | 619 | 1,663 | 165 | $8,314 |
| Metformin Hcl Generic | 597 | 1,713 | 166 | $4,156 |
| Metoprolol Succinate Generic | 564 | 1,546 | 152 | $7,686 |
| Rosuvastatin Calcium Generic | 540 | 1,495 | 147 | $7,013 |
| Pantoprazole Sodium Generic | 521 | 1,331 | 144 | $6,612 |
| Gabapentin Generic | 488 | 1,219 | 144 | $8,998 |
| Simvastatin Generic | 463 | 1,324 | 126 | $3,147 |
| Furosemide Generic | 447 | 1,123 | 124 | $1,908 |
| Hydrochlorothiazide Generic | 370 | 1,058 | 106 | $1,576 |
Brand drugs: 2,990 claims; generic drugs: 22,594 claims; opioid claims: 723.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mark F Berntsen were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.